MarketInOut Stock Screener Log In | Sign Up
 

iSpecimen Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
iSpecimen Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.1 mln
Float2.52 mln
Earnings Date11/17/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-8.62
Highly reliable

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.14
Very low leverage

Pre-Tax Margin

-2,449%
Severely loss-making

ROE

-612
Deeply negative

Business Description

iSpecimen Inc. runs an online platform that connects medical researchers with hospitals, labs, and other organizations that collect and store human biological samples. Through this platform, researchers can source a wide range of materials, including blood, tissue, and specialized cells needed for scientific studies and medical testing. The company serves clients across the pharmaceutical, diagnostic, and academic sectors. Founded in 2009 and based in Woburn, Massachusetts, iSpecimen helps streamline access to the human samples that drive life science research forward.

Key Fundamentals

EPS-52.98
ROE-612
RPS0.90
ROIC-236
ROA-148
Interest Cover-3,968
EBITDA, mln-10.22
EV / EBITDA0.15
EV / EBIT0.13
Revenue, mln0.47

Quote Details

Last 0.817
Change -0.0157 (-1.89%)
Open 0.80
Volume 38,722
Turnover 31,636
Average Volume 147,877

Financial Ratios

Pre-Tax Profit Margin-2,449
Leverage Ratio4.26
Current Ratio0.82
Price / Book1.04
Debt / Equity0.14
Price / Sales0.76

Financial Strength

Altman Z-Score-21.15
Piotroski F-Score 3 / 9
Beneish M-Score-8.62
Short Ratio0.12
Short % of Float6.39

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.91% 8 / 100   
1 Month -34.64% 9 / 100   
2 Months -64.78% 5 / 100   
6 Months -84.35% 3 / 100   
1 Year -97.31% 2 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog